Patrick R. Trucchio
Stock Analyst at HC Wainwright & Co.
(4.35)
# 344
Out of 5,127 analysts
52
Total ratings
56%
Success rate
19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick R. Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QURE uniQure | Reiterates: Buy | $70 | $26.05 | +168.71% | 6 | Feb 10, 2026 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.40 | +2,400.00% | 2 | Feb 10, 2026 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $33.26 | +200.66% | 2 | Feb 4, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $570 → $510 | $320.00 | +59.38% | 3 | Jan 30, 2026 | |
| GOSS Gossamer Bio | Reiterates: Buy | $10 | $2.26 | +342.48% | 1 | Jan 22, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $85 → $100 | $62.64 | +59.64% | 4 | Jan 21, 2026 | |
| DRUG Bright Minds Biosciences | Reiterates: Buy | $115 | $74.88 | +53.58% | 3 | Dec 30, 2025 | |
| VIR Vir Biotechnology | Reiterates: Buy | $15 | $7.28 | +106.04% | 2 | Dec 30, 2025 | |
| ASMB Assembly Biosciences | Reiterates: Buy | $50 | $26.90 | +85.87% | 2 | Dec 22, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $40 | $1.99 | +1,910.05% | 4 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.48 | +575.68% | 1 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $27.01 | +122.14% | 3 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $37.08 | +48.35% | 2 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $0.86 | +1,058.35% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $25 | $3.71 | +573.85% | 2 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $15.37 | +127.72% | 1 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $1.48 | +575.68% | 3 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $50 | $16.84 | +196.91% | 2 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $4.69 | +155.86% | 2 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $27.28 | +193.26% | 2 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $3.94 | +281.19% | 1 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $4.51 | +1,562.97% | 1 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $7.23 | +591.56% | 2 | Sep 12, 2025 |
uniQure
Feb 10, 2026
Reiterates: Buy
Price Target: $70
Current: $26.05
Upside: +168.71%
Sangamo Therapeutics
Feb 10, 2026
Reiterates: Buy
Price Target: $10
Current: $0.40
Upside: +2,400.00%
Immunocore Holdings
Feb 4, 2026
Reiterates: Buy
Price Target: $100
Current: $33.26
Upside: +200.66%
Alnylam Pharmaceuticals
Jan 30, 2026
Maintains: Buy
Price Target: $570 → $510
Current: $320.00
Upside: +59.38%
Gossamer Bio
Jan 22, 2026
Reiterates: Buy
Price Target: $10
Current: $2.26
Upside: +342.48%
Arrowhead Pharmaceuticals
Jan 21, 2026
Maintains: Buy
Price Target: $85 → $100
Current: $62.64
Upside: +59.64%
Bright Minds Biosciences
Dec 30, 2025
Reiterates: Buy
Price Target: $115
Current: $74.88
Upside: +53.58%
Vir Biotechnology
Dec 30, 2025
Reiterates: Buy
Price Target: $15
Current: $7.28
Upside: +106.04%
Assembly Biosciences
Dec 22, 2025
Reiterates: Buy
Price Target: $50
Current: $26.90
Upside: +85.87%
NRx Pharmaceuticals
Dec 16, 2025
Reiterates: Buy
Price Target: $40
Current: $1.99
Upside: +1,910.05%
Dec 8, 2025
Initiates: Buy
Price Target: $10
Current: $1.48
Upside: +575.68%
Dec 3, 2025
Reiterates: Buy
Price Target: $60
Current: $27.01
Upside: +122.14%
Nov 24, 2025
Reiterates: Buy
Price Target: $55
Current: $37.08
Upside: +48.35%
Nov 17, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $0.86
Upside: +1,058.35%
Nov 12, 2025
Maintains: Buy
Price Target: $30 → $25
Current: $3.71
Upside: +573.85%
Nov 10, 2025
Maintains: Buy
Price Target: $40 → $35
Current: $15.37
Upside: +127.72%
Nov 3, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $1.48
Upside: +575.68%
Oct 24, 2025
Maintains: Buy
Price Target: $10 → $50
Current: $16.84
Upside: +196.91%
Oct 20, 2025
Reiterates: Buy
Price Target: $12
Current: $4.69
Upside: +155.86%
Oct 10, 2025
Reiterates: Buy
Price Target: $80
Current: $27.28
Upside: +193.26%
Sep 23, 2025
Reiterates: Buy
Price Target: $15
Current: $3.94
Upside: +281.19%
Sep 16, 2025
Reiterates: Buy
Price Target: $75
Current: $4.51
Upside: +1,562.97%
Sep 12, 2025
Reiterates: Buy
Price Target: $50
Current: $7.23
Upside: +591.56%